| pubmed-article:18077217 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18077217 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18077217 | lifeskim:mentions | umls-concept:C0346647 | lld:lifeskim |
| pubmed-article:18077217 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:18077217 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
| pubmed-article:18077217 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:18077217 | lifeskim:mentions | umls-concept:C0995188 | lld:lifeskim |
| pubmed-article:18077217 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:18077217 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:18077217 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:18077217 | pubmed:dateCreated | 2008-1-7 | lld:pubmed |
| pubmed-article:18077217 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18077217 | pubmed:abstractText | Preclinical data have suggested a synergistic effect of cetuximab combined with gemcitabine and cisplatin and clinical data have shown a substantial improvement in response and survival when gemcitabine is combined with a platinum analogue compared with gemcitabine alone. The aim of this study was to assess the activity and feasibility of a combination of cetuximab with gemcitabine and cisplatin compared with use of gemcitabine and cisplatin alone for the treatment of advanced pancreatic cancer. | lld:pubmed |
| pubmed-article:18077217 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18077217 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18077217 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18077217 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18077217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18077217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18077217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18077217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18077217 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18077217 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18077217 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:18077217 | pubmed:issn | 1474-5488 | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:CascinuStefan... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:ScartozziMari... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:ToniniGiusepp... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:LabiancaRober... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:FalconeAlfred... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:BarniSandroS | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:Di... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:ZaniboniAlber... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:SienaSalvator... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:FlorianiIrene... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:ArtaleSalvato... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:BerardiRossan... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:AitiniEnricoE | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:Italian... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:PierantoniChi... | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:RotaSilviaS | lld:pubmed |
| pubmed-article:18077217 | pubmed:author | pubmed-author:DaprettoElisa... | lld:pubmed |
| pubmed-article:18077217 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18077217 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:18077217 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18077217 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18077217 | pubmed:pagination | 39-44 | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:meshHeading | pubmed-meshheading:18077217... | lld:pubmed |
| pubmed-article:18077217 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18077217 | pubmed:articleTitle | Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial. | lld:pubmed |
| pubmed-article:18077217 | pubmed:affiliation | Polytechnic University of Marche-Riuniti Hospital Umberto I-GM Lancisi-G Salesi of Ancona, 60020 Ancona, Italy. cascinu@yahoo.com | lld:pubmed |
| pubmed-article:18077217 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18077217 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:18077217 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:18077217 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077217 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077217 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077217 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077217 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077217 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077217 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077217 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077217 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077217 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077217 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18077217 | lld:pubmed |
